About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Lyn
LYN proto-oncogene, Src family tyrosine kinase
MGI:96892
111 phenotypes from 14 alleles in 18 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Lynm1Anu/Lynm1Anu
C57BL/6JAnu-Lynm1Anu 		decreased B cell number J:195155
LynM1Btlr/Lyn+
C57BL/6J-LynM1Btlr 		decreased B cell number J:214511
increased neutrophil cell number J:214511
LynM1Btlr/LynM1Btlr
C57BL/6J-LynM1Btlr 		decreased B cell number J:214511
increased neutrophil cell number J:214511
Lynm2Anu/Lynm2Anu
C57B/6JAnu-Lynm2Anu/AnuApb 		decreased mature B cell number J:104190
increased immature B cell number J:104190
LynM2Btlr/Lyn+
C57BL/6J-LynM2Btlr 		decreased IgG level J:217146
decreased IgM level J:217146
impaired humoral immune response J:217146
LynM2Btlr/LynM2Btlr
C57BL/6J-LynM2Btlr 		decreased IgG level J:217146
decreased IgM level J:217146
impaired humoral immune response J:217146
LynM3Btlr/Lyn+
C57BL/6J-LynM3Btlr 		decreased T cell number J:236679
impaired hematopoiesis J:236679
increased B-1 B cell number J:236679
increased dendritic cell number J:236679
increased macrophage cell number J:236679
LynM3Btlr/LynM3Btlr
C57BL/6J-LynM3Btlr 		decreased T cell number J:236679
impaired hematopoiesis J:236679
increased B-1 B cell number J:236679
increased dendritic cell number J:236679
increased macrophage cell number J:236679
Lynm4Btlr/Lynm4Btlr
C57BL/6J-Lynm4Btlr 		decreased IgG level J:272816
impaired humoral immune response J:272816
Lynmld4/Lynmld4
involves: C57BL/6 		abnormal B cell activation J:144799
abnormal B cell morphology J:144799
abnormal myelopoiesis J:144799
decreased follicular B cell number J:144799
decreased marginal zone B cell number J:144799
decreased transitional stage B cell number J:144799
glomerulonephritis J:144799
increased anti-double stranded DNA antibody level J:144799
increased erythroid progenitor cell number J:144799
increased IgE level J:144799
increased IgM level J:144799
increased macrophage cell number J:144799
increased neutrophil cell number J:144799
increased T cell number J:144799
peritoneal inflammation J:144799
renal glomerular immunoglobulin deposits J:144799
spleen hypoplasia J:144799
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0
involves: 129P2/OlaHsd * C57BL/6 * CBA 		abnormal circulating chemokine level J:200745
abnormal circulating cytokine level J:200745
abnormal dendritic cell physiology J:200745
abnormal leukocyte physiology J:200745
abnormal T cell activation J:200745
enlarged lymph nodes J:200745
enlarged spleen J:200745
glomerulonephritis J:200745
increased activated T cell number J:200745
increased autoantibody level J:200745
increased circulating interferon-gamma level J:200745
increased circulating interleukin-1 beta level J:200745
increased circulating interleukin-6 level J:200745
increased circulating interleukin-12 level J:200745
increased circulating interleukin-17 level J:200745
increased circulating tumor necrosis factor level J:200745
increased dendritic cell number J:200745
increased granulocyte number J:200745
increased inflammatory response J:200745
increased leukocyte cell number J:200745
increased monocyte cell number J:200745
increased plasma cell number J:200745
increased T cell number J:200745
liver inflammation J:200745
lung inflammation J:200745
lymph node hyperplasia J:200745
myeloid hyperplasia J:200745
premature death J:200745
renal glomerular immunoglobulin deposits J:200745
skin inflammation J:200745
skin lesions J:200745
Lyntm1Ard/Lyntm1Ard
B6.129P2-Lyntm1Ard 		abnormal B cell activation J:144799
abnormal B cell morphology J:144799
abnormal myelopoiesis J:144799
decreased follicular B cell number J:144799
decreased marginal zone B cell number J:144799
decreased transitional stage B cell number J:144799
glomerulonephritis J:144799
increased anti-double stranded DNA antibody level J:144799
increased anti-nuclear antigen antibody level J:144799
increased T cell number J:144799
peritoneal inflammation J:144799
renal glomerular immunoglobulin deposits J:144799
spleen hypoplasia J:144799
Lyntm1Ard/Lyntm1Ard
involves: 129P2/OlaHsd 		abnormal circulating complement protein level J:161523
abnormal level of surface class II molecules J:161523
albuminuria J:161523
decreased spleen red pulp amount J:72269
decreased spleen white pulp amount J:72269
enlarged spleen J:72269
extramedullary hematopoiesis J:72269
glomerulonephritis J:161523
increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
increased basophil cell number J:161523
increased IgA level J:161523
increased IgE level J:161523
increased IgG2b level J:161523
increased IgM level J:161523
increased mast cell number J:161523
increased neutrophil cell number J:72269
thrombocytopenia J:72269
Lyntm1b(EUCOMM)Hmgu/Lyntm1b(EUCOMM)Hmgu
C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H 		abnormal gait J:211773
abnormal maxilla morphology J:211773
abnormal retina morphology J:211773
decreased bone mineral density J:211773
decreased circulating cholesterol level J:211773
decreased circulating HDL cholesterol level J:211773
decreased circulating triglyceride level J:211773
decreased erythrocyte cell number J:211773
decreased hematocrit J:211773
decreased hemoglobin content J:211773
decreased leukocyte cell number J:211773
decreased lymphocyte cell number J:211773
enlarged spleen J:211773
increased blood urea nitrogen level J:211773
increased circulating aspartate transaminase level J:211773
increased eosinophil cell number J:211773
increased large unstained cell number J:211773
increased mean platelet volume J:211773
increased monocyte cell number J:211773
increased neutrophil cell number J:211773
increased red blood cell distribution width J:211773
increased spleen weight J:211773
small thymus J:211773
thrombocytopenia J:211773
Lyntm1Mhi/Lyntm1Mhi
involves: 129S1/Sv 		decreased spleen weight J:72269
increased neutrophil cell number J:72269
Lyntm1Sor/Lyntm1Sor
B6.129S4-Lyntm1Sor 		abnormal inflammatory response J:113463
Lyntm1Sor/Lyntm1Sor
involves: 129S4/SvJae 		decreased B cell number J:42037
decreased mature B cell number J:42037
enlarged lymph nodes J:42037
enlarged spleen J:42037
increased anti-double stranded DNA antibody level J:42037
increased B cell proliferation J:42037
Lyntm1Sor/Lyntm1Sor
involves: 129S4/SvJaeSor 		abnormal chemokine level J:80658
abnormal circulating chemokine level J:200745
abnormal circulating cytokine level J:200745
abnormal dendritic cell physiology J:200745
abnormal macrophage physiology J:80658
abnormal microglial cell physiology J:80658
abnormal proerythroblast morphology J:146561
decreased B cell number J:200745
decreased follicular B cell number J:146161
decreased marginal zone B cell number J:146161
decreased mature B cell number J:146161
decreased transitional stage B cell number J:146161
glomerulonephritis J:146161, J:200745
glomerulosclerosis J:146161
increased anti-double stranded DNA antibody level J:146161
increased autoantibody level J:200745
increased B cell proliferation J:146161
increased circulating interferon-gamma level J:200745
increased circulating interleukin-6 level J:200745
increased circulating interleukin-12 level J:200745
increased circulating interleukin-17 level J:200745
increased erythroid progenitor cell number J:146561
increased IgA level J:146161
increased IgM level J:146161
increased plasma cell number J:200745
liver inflammation J:146161
mesangial cell interposition J:146161
myeloid hyperplasia J:146161
renal glomerular protein deposits J:200745
renal glomerulus hypertrophy J:146161
spleen hyperplasia J:146161
Lyntm1Sor/Lyntm1Sor
involves: 129S4/SvJaeSor * C57BL/6 		decreased B cell number J:71174
decreased B-1 B cell number J:71174
decreased mature B cell number J:71174
enlarged spleen J:71174
glomerulonephritis J:71174
increased anti-double stranded DNA antibody level J:71174
increased B cell proliferation J:71174
increased IgA level J:71174
increased IgG1 level J:71174
increased IgG2b level J:71174
increased IgG level J:71174
increased IgM level J:71174
increased susceptibility to systemic lupus erythematosus J:71174
Lyntm1Tya/Lyntm1Tya
involves: 129P2/OlaHsd * C57BL/6 		abnormal B cell physiology J:29751
abnormal class switch recombination J:29751
abnormal spleen morphology J:29751
anemia J:29751
decreased B cell number J:29751
decreased B cell proliferation J:29751
decreased lymphocyte cell number J:29751
enlarged lymph nodes J:29751
enlarged spleen J:29751
glomerulonephritis J:29751
increased anti-double stranded DNA antibody level J:29751
increased IgA level J:29751
increased IgM level J:29751
increased immunoglobulin level J:29751
increased spleen white pulp amount J:29751
premature death J:29751
small Peyer's patches J:29751
Lynweeb/Lynweeb
C57BL/6-Lynweeb 		decreased follicular B cell number J:146161
decreased marginal zone B cell number J:146161
decreased mature B cell number J:146161
decreased transitional stage B cell number J:146161
disorganized spleen B cell follicle J:146161
glomerulonephritis J:146161
glomerulosclerosis J:146161
increased anti-double stranded DNA antibody level J:146161
increased B cell proliferation J:146161
increased IgM level J:146161
liver inflammation J:146161
mesangial cell interposition J:146161
renal glomerulus hypertrophy J:146161
spleen hyperplasia J:146161
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/18/2025
MGI 6.24 		The Jackson Laboratory